4
Changes in Ownership
Immuneering Corp Filed Acc 0001628280-24-028072
Options or other derivatives
- Director acquired 8,588 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schall Thomas J. Director | 2024-06-12 | Grant or award · Stock Option | +8,588 | 8,588 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1718310353.xml…